Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of patients with combined hyperlipidemia

被引：0
|
作者：
Koh, KK
Han, SH
Quon, MJ
Chung, WJ
Shin, MS
Ahn, TH
Choi, IS
Shin, EK
机构：
[1] Gachon Med Sch, Inchon, South Korea
[2] NIH, Bethesda, MD 20892 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2005年 / 45卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：394A / 394A
页数：1
相关论文
共 50 条
  • [41] Comparison of atorvastatin versus fenofibrate in reaching lipid targets and influencing biomarkers of endothelial damage in patients with familial combined hyperlipidemia
    Arca, Marcello
    Montali, Anna
    Pigna, Giovanni
    Antonini, Roberto
    Antonini, Teresa Maria
    Luigi, Petrarnala
    Fraioli, Antonio
    Mastrantoni, Marco
    Maddaloni, Maura
    Letizia, Claudio
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2007, 56 (11): : 1534 - 1541
  • [42] MTP gene polymorphisms and postprandial lipemia in familial combined hyperlipidemia: Effects of treatment with atorvastatin
    Klop, Boudewijn
    Verseyden, Caroline
    Ribalta, Josep
    Salazar, Juliana
    Masana, Luis
    Cabezas, Manuel Castro
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2014, 26 (02): : 49 - 57
  • [43] Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia
    Cohn, JS
    Tremblay, M
    Batal, R
    Jacques, H
    Veilleux, L
    Rodriguez, C
    Barrett, RHR
    Dubreuil, D
    Roy, M
    Bernier, L
    Mamer, O
    Davignon, J
    JOURNAL OF LIPID RESEARCH, 2002, 43 (09) : 1464 - 1471
  • [44] Effects of atorvastatin and fenofibrate on postprandial lipemia in type 2 diabetic patients with hyperlipidemia
    Iovine, C
    Lilli, S
    Gentile, A
    Patti, L
    Di Marino, L
    Cipriano, P
    Riccardi, G
    Rivellese, AA
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 110 - 110
  • [45] Fluvastatin vs fluvastatin plus fenofibrate in CHD patients and combined hyperlipidemia
    Widimsky, J
    Hulinsky, V
    Balazovjech, I
    Lanska, V
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 63 - 63
  • [46] Losartan combined with simvastatin shows additive beneficial effects on inflammation in the treatment of hypercholesterolemic, hypertensive patients
    Koh, KK
    Han, SH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 359A - 359A
  • [47] Comparison of the efficacy of atorvastatin and micronised fenofibrate in the treatment of mixed hyperlipidemia
    Miltiadous, G
    Bairaktari, E
    Tzallas, C
    Tsimihodimos, V
    Liberopoulos, E
    Millionis, H
    Rizos, E
    Elisaf, M
    ATHEROSCLEROSIS, 1999, 144 : 37 - 37
  • [48] Comparison of the efficacy of atorvastatin and micronized fenofibrate in the treatment of mixed hyperlipidemia
    Bairaktari, ET
    Tzallas, CS
    Tsimihodimos, VK
    Liberopoulos, EN
    Miltiadous, GA
    Elisaf, MS
    JOURNAL OF CARDIOVASCULAR RISK, 1999, 6 (02): : 113 - 116
  • [49] Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia
    Ellen, RLB
    McPherson, R
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (4A): : 60B - 65B
  • [50] Effect of low dose of atorvastatin on hyperhomocysteinemic patients with associated combined hyperlipidemia
    Díaz-Peromingo, JA
    Albán-Salgado, A
    Sánchez-Leira, J
    García-Suárez, F
    Padín-Paz, E
    Saborido-Froján, J
    Iglesias-Gallego, M
    Fernández-Ameneiros, MJ
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 105 - 106
12345